Search results
Results from the WOW.Com Content Network
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...
This page was last edited on 8 December 2020, at 18:30 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Sanofi-Aventis – Sanofi-Aventis Ltd; Sanofi Pasteur – Sanofi Pasteur MSD Ltd; Sanofi-Synthélabo – Sanofi-Aventis Ltd; Schering-Plough – Schering-Plough Ltd; Schwarz – Schwarz Pharma Ltd; Searle – Pfizer Ltd; Seqirus - was Novartis Vaccines Serono – Serono Pharmaceuticals Ltd; Servier – Servier Laboratories Ltd; Shire – Shire ...
Sanofi: Health care Pharmaceuticals Paris: 2004 Formed by merger of Sanofi-Synthélabo and Aventis (the original incarnation of Sanofi was established in 1973) P A Schneider Electric: Industrials Electrical components & equipment Rueil-Malmaison: 1836 Energy and automation equipment P A SCOR SE : Financials Reinsurance Paris: 1970 Reinsurance P A
The company is a subsidiary of the French multinational pharmaceutical company Sanofi. The company’s brands are sold nationally through mass merchandiser, drug and food retailers. In 2005, 70% of the firm's sales were made through its top ten customers, which include Wal-Mart , Walgreens , and Kroger.
The former Hoechst AG and today's Industriepark Höchst. Hoechst AG (German pronunciation: [ˈhøːçst]) was a German chemicals, later life sciences, company that became Aventis Deutschland after its merger with France's Rhône-Poulenc S.A. in 1999.
Agfa, BASF and Bayer remained in business; Hoechst spun off its chemical business in 1999 as Celanese AG before merging with Rhône-Poulenc to form Aventis, which later merged with Sanofi-Synthélabo to form Sanofi. Two years earlier, another part of Hoechst was sold in 1997 to the chemical spin-off of Sandoz, the Muttenz (Switzerland) based ...
Paul Hudson (born 14 October 1967) [2] is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales. [ 3 ] Early life